CESAR is looking for hospitals to be among the first to participate in pioneering nationwide launch of the Emergency Department Drug Surveillance (EDDS) system sponsored by the Office of National Drug Control Policy.
Hospitals provide selected EHR information quarterly to EDDS, including ED patient urinalysis results, to enable them to analyze trends in their drug test results. EDDS also offers each hospital one-time free testing of up to 150 urine specimens for 490 drugs so that they can gain a fuller picture of the drugs their patients have recently used and allows them to educate their patients and update their routine urinalysis test panels, as needed. EDDS data can also be used to analyze how COVID-19 has affected ED admissions. CESAR staff work with each hospital to prepare IRB materials, create exports of selected EHR information and to prepare de-identified urine specimens for shipping to a collaborating laboratory at no cost.
For more information, download the EDDS Factsheet.